Skip to the main content

Biochemia Medica, Vol. 35 No. 1, 2025.

Erratum

https://doi.org/10.11613/BM.2025.011201

Corrigendum to: Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers

Gramos Begolli
Maja Lukić ; Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia; Faculty of Medicine, JJ Strossmayer University of Osijek, Osijek, Croatia
Lada Rumora ; Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
Lorna Čorak ; University Hospital Center Zagreb, Zagreb, Croatia
Andrea Vukić Dugac ; University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia
Marko Jakopović ; University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia
Miroslav Samaržija ; University Hospital Center Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia
Ilijan Tomaš ; Faculty of Medicine, JJ Strossmayer University of Osijek, Osijek, Croatia; Oncology Department, University Hospital Centre Osijek, Osijek, Croatia
Jelena Knežević ; Laboratory for Advanced Genomics, Ruđer Bošković Institute, Zagreb, Croatia; Faculty for Dental Medicine and Health, JJ Strossmayer University of Osijek, Osijek, Croatia
Željko Debeljak orcid id orcid.org/0000-0002-1789-5387 ; Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia; Faculty of Medicine, JJ Strossmayer University of Osijek, Osijek, Croatia *

* Corresponding author.

Full text: english pdf 39 Kb

page 144-144

downloads: 61

cite

Download JATS file

Abstract

Keywords

Hrčak ID:

328193

URI

https://hrcak.srce.hr/328193

Publication date:

15.2.2025.

Visits: 321 *

Copyright statement: Croatian Society of Medical Biochemistry and Laboratory Medicine.

Copyright: 2025, Croatian Society of Medical Biochemistry

License (open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publication date: 15 February 2025

Publication date: 15 February 2025

Volume: 35

Issue: 1

Electronic Location Identifier: 011201

Related article (corrected article):

Publisher ID: bm-35-1-011201

DOI: 10.11613/BM.2025.011201

Corrigendum to: Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers

Gramos Begolli[1]

Maja Lukić[2][3]

Lada Rumora[4]

Lorna Čorak[5]

Andrea Vukić Dugac[5][6]

Marko Jakopović[5][6]

Miroslav Samaržija[5][6]

Ilijan Tomaš[3][7]

Jelena Knežević[8][9]

Željko Debeljak[*][2][3]

 

[1] Clinic of Medical Biochemistry, University Clinical Center of Kosovo, Pristina, Kosovo

[2] Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia

[3] Faculty of Medicine, JJ Strossmayer University of Osijek, Osijek, Croatia

[4] Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia

[5] University Hospital Center Zagreb, Zagreb, Croatia

[6] School of Medicine, University of Zagreb, Zagreb, Croatia

[7] Oncology Department, University Hospital Centre Osijek, Osijek, Croatia

[8] Laboratory for Advanced Genomics, Ruđer Bošković Institute, Zagreb, Croatia

[9] Faculty for Dental Medicine and Health, JJ Strossmayer University of Osijek, Osijek, Croatia

Author notes:

Correspondence to: [*] Corresponding author: zeljko.debeljak@gmail.com

Highlights

• In pneumonia and chronic obstructive pulmonary disease (COPD), median pro-gastrin-releasing peptide (proGRP) > 50 ng/L was measured

• Median proGRP < 40 ng/L was measured in the early-stage lung adenocarcinoma and squamous cell carcinoma

• Pneumonia and COPD patients may have higher proGRP cut-offs compared to small-cell lung cancer

This is a correction of Biochem Med (Zagreb). 2025;35:010702. DOI:https://doi.org/10.11613/BM.2025.010702

Since the publication of the article, the authors have noticed an error in the Highlights section. The correct Highlights are presented above. We apologize to the authors for any inconvenience caused to the readers.

This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.